Myriad Genetic Laboratories

Myriad Genetics is a leading precision medicine company that develops and commercializes molecular diagnostic tests designed to assess a patient's risk of developing hereditary diseases and guide personalized treatment plans. The company is best known for its pioneering work in hereditary cancer, specifically with the BRACAnalysis test for BRCA1 and BRCA2 mutations. Beyond oncology, Myriad provides pharmacogenomic testing through its GeneSight platform to help clinicians select appropriate medications for mental health conditions based on a patient's genetic profile. By integrating genetic insights into routine clinical care, Myriad aims to improve patient outcomes and reduce healthcare costs across oncology, women's health, and mental health. The company operates high-complexity clinical laboratories that provide actionable insights to healthcare providers worldwide.